Ningyu Wang

2.5k citations
84 papers · 1.5k · h-index 22

Impact in

  • Toxicology top 5%
    • Protein Degradation and Inhibitors
    • Epigenetics and DNA Methylation
    • Cancer therapeutics and mechanisms
    • Ubiquitin and proteasome pathways
    • Histone Deacetylase Inhibitors Research
    • Cancer-related gene regulation

Papers in

    • Protein Degradation and Inhibitors 12
    • Epigenetics and DNA Methylation 10
    • Ubiquitin and proteasome pathways 9
    • Cancer therapeutics and mechanisms 8
    • Biochemical and Molecular Research 7
    • RNA modifications and cancer 7
    • Cancer-related gene regulation 7

Ningyu Wang

80 papers receiving 1.4k citations

Peers

Ningyu Wang
Comparison fields: 5 of 99
  • Toxicology 46
  • Molecular Biology 918
  • Organic Chemistry 338
  • Oncology 307
  • Infectious Diseases 127
Replace Yongxia Zhu with:
Yongxia Zhu China
Ramesh Ummanni India
Stefania Ferrari Italy
Chao‐Yun Cai China
Amrita V. Kamath United States
Hariprasad Vankayalapati United States
Kentaro Yoshimatsu Japan
Jason R. Thomas United States
Clarissa Araújo Gurgel Rocha Brazil
Claire A. Minshull United Kingdom
Ningyu Wang relative to Yongxia Zhu China Yongxia Zhu's profile →
Citations per field
00.5×1.5×2.0×
Yongxia Zhu · 1×
Citations per year

Countries citing papers authored by Ningyu Wang

Since Specialization
Citations

This map shows the geographic impact of Ningyu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningyu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningyu Wang more than expected).

Fields of papers citing papers by Ningyu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ningyu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningyu Wang. The network helps show where Ningyu Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Ningyu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ningyu Wang Line = papers co-authored together Ningyu Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014112
2 202195
3 201776
4 201664
5 201356
6 201456
7 201650
8 201848
9 201445
10 201443
11 201541
12 201740
13 201639
14 202137
15 201537
16 201435
17 202034
18 201432
19 201628
20 201822

About Ningyu Wang

Ningyu Wang is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 84 papers that have together received 1.5k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (12 papers), Epigenetics and DNA Methylation (10 papers), Ubiquitin and proteasome pathways (9 papers), Cancer therapeutics and mechanisms (8 papers), Biochemical and Molecular Research (7 papers), RNA modifications and cancer (7 papers), Cancer-related gene regulation (7 papers) and Hepatitis C virus research (7 papers). The work is most often cited by research in Toxicology (46 citations), Molecular Biology (918 citations), Organic Chemistry (338 citations), Oncology (307 citations) and Infectious Diseases (127 citations). Ningyu Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Luoting Yu, Tinghong Ye, Yongxia Zhu, Yong Xia, Xuejiao Song, Yuquan Wei, Qian Lei, Zhihao Liu, Cuiting Peng and Weiqiong Zuo. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, RSC Advances and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact